SP17 Inhibitors
The chemical class of SP17 Inhibitors, while not directly targeting SP17, focuses on influencing cellular processes and pathways that may indirectly impact SP17's function or expression. SP17's role in cell motility and its potential expression in cancer cells suggest that its activity could be modulated by changes in cellular dynamics and signaling.
The inhibitors listed predominantly affect cellular structures and functions such as the Golgi apparatus, microtubules, actin filaments, and energy metabolism. Compounds like Brefeldin A, Monensin, Nocodazole, Colchicine, Paclitaxel, Vinblastine, and Vincristine target the cytoskeletal elements and intracellular transport, which could indirectly influence SP17, particularly if it is involved in processes like cell motility or division. Additionally, compounds that alter cellular metabolism (such as 2-Deoxy-D-glucose) or are involved in chemotherapy (like Cisplatin, Methotrexate, and Doxorubicin) can impact cell proliferation, survival, and protein expression. These changes might indirectly affect SP17, especially in cancer cells where SP17 may have a role in tumorigenesis or metastasis.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts the Golgi apparatus and can affect protein trafficking and secretion, potentially influencing processes where SP17 might be involved. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Monensin is an ionophore that disrupts Golgi function. It could indirectly affect SP17 by altering the cellular processes related to protein trafficking and modification. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Nocodazole disrupts microtubule dynamics, which could influence cellular processes related to SP17, particularly if SP17 is involved in cell motility or division. | ||||||
Colchicine | 64-86-8 | sc-203005 sc-203005A sc-203005B sc-203005C sc-203005D sc-203005E | 1 g 5 g 50 g 100 g 500 g 1 kg | $100.00 $321.00 $2289.00 $4484.00 $18207.00 $34749.00 | 3 | |
Colchicine binds to tubulin and inhibits microtubule polymerization. It can indirectly affect SP17 activity by impacting microtubule dynamics and related cellular processes. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Paclitaxel stabilizes microtubules and can affect cell division and motility. This could indirectly influence SP17, especially if it plays a role in these processes. | ||||||
Vinblastine | 865-21-4 | sc-491749 sc-491749A sc-491749B sc-491749C sc-491749D | 10 mg 50 mg 100 mg 500 mg 1 g | $102.00 $235.00 $459.00 $1749.00 $2958.00 | 4 | |
Vinblastine is a microtubule-disrupting agent. It can indirectly affect processes where SP17 might be involved, particularly in the context of cell motility or structure. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Cytochalasin D disrupts actin filaments, which could indirectly influence SP17 if it is involved in cell motility or morphology. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
2-Deoxy-D-glucose inhibits glycolysis and can impact energy metabolism in cells. This might indirectly affect SP17 activity, especially in energy-dependent cellular processes. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Cisplatin is a chemotherapy drug that causes DNA damage. While not directly targeting SP17, it can influence cellular processes and the expression of various proteins, potentially including SP17. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Methotrexate is an antimetabolite drug that can affect DNA synthesis and cell division. It could indirectly influence SP17, particularly if SP17 is involved in these processes. | ||||||